Toronto - Delayed Quote CAD

Oncolytics Biotech Inc. (ONC.TO)

1.4700 -0.0200 (-1.34%)
At close: April 26 at 3:59 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for ONC.TO

Recent News: ONC.TO

View More
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
PR Newswire 2 days ago
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
PR Newswire 16 days ago
Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference

Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference
CNW Group 25 days ago
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript
Insider Monkey last month
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
CNW Group last month
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning

Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
Newsfile last month
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN

Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
CNW Group last month
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
CNW Group last month
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference

Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference
PR Newswire last month
Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation
Simply Wall St. 2 months ago
Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
Newsfile 2 months ago
Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort

Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort
CNW Group 2 months ago
View More

Related Tickers

TH.TO Theratechnologies Inc.
1.8000
0.00%
 
APS.TO Aptose Biosciences Inc.
1.7000
+4.94%
 
SVA.TO Sernova Corp.
0.4400
+3.53%
 
MDNA.TO Medicenna Therapeutics Corp.
2.4900
+27.69%
 
HBP.TO Helix BioPharma Corp.
0.2100
0.00%
 
AEZS.TO Aeterna Zentaris Inc.
2.6500
-0.38%
 
MBX.TO Microbix Biosystems Inc.
0.3250
-2.99%
 
ATE.TO Antibe Therapeutics Inc.
0.2950
0.00%
 
BCT.TO BriaCell Therapeutics Corp.
2.9300
-2.66%
 
XRTX.V XORTX Therapeutics Inc.
4.0700
+12.43%